{"count": 2, "results": [{"_id": "12782", "pmid": 12782, "title": "Atenolol versus propranolol. A comparison of ocular hypotensive effect of an oral dose.", "journal": "Br J Ophthalmol", "authors": ["Macdonald MJ", "Cullen PM", "Phillips CI"], "date": "1976-11-01T00:00:00Z", "doi": "10.1136/bjo.60.11.789", "meta_date_publication": "1976 Nov", "meta_volume": "60", "meta_issue": "11", "meta_pages": "789-91", "score": 50070.113, "text_hl": "In a controlled double-blind cross-over trial in 10 patients comprising six with @DISEASE_Glaucoma_Open_Angle @DISEASE_MESH:D005902 @@@open-angle glaucoma@@@, three with @<m>DISEASE_Glaucoma_Angle_Closure</m> @DISEASE_MESH:D015812 @@@closed-angle glaucoma@@@, and one with @DISEASE_Ocular_Hypertension @DISEASE_MESH:D009798 @@@ocular hypertension@@@, a single oral dose of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ (50 mg) was significantly more effective than @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ (40 mg) in reducing ocular tension.", "citations": {"NLM": "Macdonald MJ, Cullen PM, Phillips CI. Atenolol versus propranolol. A comparison of ocular hypotensive effect of an oral dose. Br J Ophthalmol. 1976 Nov;60(11):789-91. PMID: 12782", "BibTeX": "@article{12782, title={Atenolol versus propranolol. A comparison of ocular hypotensive effect of an oral dose.}, author={Macdonald MJ and Cullen PM and Phillips CI}, journal={Br J Ophthalmol}, volume={60}, number={11}, pages={789-91}}"}}, {"_id": "326303", "pmid": 326303, "title": "Atenolol eye drops in glaucoma: a double-masked, controlled study.", "journal": "Br J Ophthalmol", "authors": ["Phillips CI", "Gore SM", "Macdonald MJ", "Cullen PM"], "date": "1977-05-01T00:00:00Z", "doi": "10.1136/bjo.61.5.349", "meta_date_publication": "1977 May", "meta_volume": "61", "meta_issue": "5", "meta_pages": "349-53", "score": 50067.24, "text_hl": "...Guttae @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ 4% (@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Tenormin@@@), a pure beta1-blocking (i.e., cardioselective) drug, produced a median overall fall of 5-6 mmHg (range 3-2 to 13-2 mmHg) in the first tonometrised eyes of 7 @SPECIES_9606 @@@patients@@@ with @DISEASE_Glaucoma_Open_Angle @DISEASE_MESH:D005902 @@@open-angle glaucoma@@@ or @DISEASE_Ocular_Hypertension @DISEASE_MESH:D009798 @@@ocular hypertension@@@ and 1 with @<m>DISEASE_Glaucoma_Angle_Closure</m> @DISEASE_MESH:D015812 @@@closed-angle glaucoma@@@ (off any treatment for the whole of the day preceding each test day) after allowance for an 'effect' of guttae saline 0-9%, in a double-masked, cross-over trial. ", "citations": {"NLM": "Phillips CI, Gore SM, Macdonald MJ, Cullen PM. Atenolol eye drops in glaucoma: a double-masked, controlled study. Br J Ophthalmol. 1977 May;61(5):349-53. PMID: 326303", "BibTeX": "@article{326303, title={Atenolol eye drops in glaucoma: a double-masked, controlled study.}, author={Phillips CI and Gore SM and Macdonald MJ and Cullen PM}, journal={Br J Ophthalmol}, volume={61}, number={5}, pages={349-53}}"}}]}